254 related articles for article (PubMed ID: 31123883)
21. Nongenetically modified Lactococcus lactis-adjuvanted vaccination enhanced innate immunity against Helicobacter pylori.
Liu W; Tan Z; Liu H; Zeng Z; Luo S; Yang H; Zheng L; Xi T; Xing Y
Helicobacter; 2017 Oct; 22(5):. PubMed ID: 28805287
[TBL] [Abstract][Full Text] [Related]
22. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice.
Ferrero RL; Thiberge JM; Kansau I; Wuscher N; Huerre M; Labigne A
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6499-503. PubMed ID: 7604021
[TBL] [Abstract][Full Text] [Related]
23. Inflammation, immunity, and vaccines for Helicobacter pylori infection.
Velin D; Straubinger K; Gerhard M
Helicobacter; 2016 Sep; 21 Suppl 1():26-9. PubMed ID: 27531535
[TBL] [Abstract][Full Text] [Related]
24. Experimental model of Helicobacter pylori infection.
Del Giudice G; Ghiara P; Rappuoli R
Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S261-3. PubMed ID: 10077750
[TBL] [Abstract][Full Text] [Related]
25. Protection against Helicobacter pylori infection in BALB/c mice by oral administration of multi-epitope vaccine of CTB-UreI-UreB.
Yang J; Dai LX; Pan X; Wang H; Li B; Zhu J; Li MY; Shi XL; Wang BN
Pathog Dis; 2015 Jul; 73(5):. PubMed ID: 25846576
[TBL] [Abstract][Full Text] [Related]
26. The role of T helper 1-cell response in Helicobacter pylori-infection.
Bagheri N; Salimzadeh L; Shirzad H
Microb Pathog; 2018 Oct; 123():1-8. PubMed ID: 29936093
[TBL] [Abstract][Full Text] [Related]
27. Inflammation, immunity, and vaccines for Helicobacter infection.
Permin H; Andersen LP
Helicobacter; 2005; 10 Suppl 1():21-5. PubMed ID: 16178967
[TBL] [Abstract][Full Text] [Related]
28. Immunity, inflammation, and vaccines for Helicobacter pylori.
D'Elios MM; Czinn SJ
Helicobacter; 2014 Sep; 19 Suppl 1():19-26. PubMed ID: 25167941
[TBL] [Abstract][Full Text] [Related]
29. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.
Sokic-Milutinovic A; Alempijevic T; Milosavljevic T
World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic oral vaccination induces mucosal immune response sufficient to eliminate long-term Helicobacter pylori infection.
Ikewaki J; Nishizono A; Goto T; Fujioka T; Mifune K
Microbiol Immunol; 2000; 44(1):29-39. PubMed ID: 10711597
[TBL] [Abstract][Full Text] [Related]
31. Immune response to H. pylori.
Suarez G; Reyes VE; Beswick EJ
World J Gastroenterol; 2006 Sep; 12(35):5593-8. PubMed ID: 17007009
[TBL] [Abstract][Full Text] [Related]
32. Chitosan as an adjuvant for a Helicobacter pylori therapeutic vaccine.
Gong Y; Tao L; Wang F; Liu W; Jing L; Liu D; Hu S; Xie Y; Zhou N
Mol Med Rep; 2015 Sep; 12(3):4123-4132. PubMed ID: 26095723
[TBL] [Abstract][Full Text] [Related]
33. A multi-epitope vaccine CTB-UE relieves Helicobacter pylori-induced gastric inflammatory reaction via up-regulating microRNA-155 to inhibit Th17 response in C57/BL6 mice model.
Lv X; Song H; Yang J; Li T; Xi T; Xing Y
Hum Vaccin Immunother; 2014; 10(12):3561-9. PubMed ID: 25483699
[TBL] [Abstract][Full Text] [Related]
34. Inflammation, immunity and vaccines for Helicobacter pylori.
Del Giudice G; Michetti P
Helicobacter; 2004; 9 Suppl 1():23-8. PubMed ID: 15347302
[TBL] [Abstract][Full Text] [Related]
35. Inflammation, Immunity, and Vaccines for Helicobacter pylori Infection.
Walduck A; Andersen LP; Raghavan S
Helicobacter; 2015 Sep; 20 Suppl 1():17-25. PubMed ID: 26372820
[TBL] [Abstract][Full Text] [Related]
36. Eradication of Helicobacter pylori and resolution of gastritis in the gastric mucosa of IL-10-deficient mice.
Matsumoto Y; Blanchard TG; Drakes ML; Basu M; Redline RW; Levine AD; Czinn SJ
Helicobacter; 2005 Oct; 10(5):407-15. PubMed ID: 16181351
[TBL] [Abstract][Full Text] [Related]
37. Local recall responses in the stomach involving reduced regulation and expanded help mediate vaccine-induced protection against Helicobacter pylori in mice.
Becher D; Deutscher ME; Simpfendorfer KR; Wijburg OL; Pederson JS; Lew AM; Strugnell RA; Walduck AK
Eur J Immunol; 2010 Oct; 40(10):2778-90. PubMed ID: 21038469
[TBL] [Abstract][Full Text] [Related]
38. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection.
Kotloff KL; Sztein MB; Wasserman SS; Losonsky GA; DiLorenzo SC; Walker RI
Infect Immun; 2001 Jun; 69(6):3581-90. PubMed ID: 11349017
[TBL] [Abstract][Full Text] [Related]
39. Preclinical immunogenicity and protective efficacy of an oral Helicobacter pylori inactivated whole cell vaccine and multiple mutant cholera toxin: A novel and non-toxic mucosal adjuvant.
Holmgren J; Nordqvist S; Blomquist M; Jeverstam F; Lebens M; Raghavan S
Vaccine; 2018 Oct; 36(41):6223-6230. PubMed ID: 30119923
[TBL] [Abstract][Full Text] [Related]
40. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
